Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device reimbursement: plan early, says US compliance consultant

This article was originally published in Clinica

Executive Summary

Thinking about the reimbursement implications of a product should be done at the product development stage, argues John Avellanet, managing director of Cerulean Associates. Here, he tells Clinica readers how to start the process of building reimbursement expectations into the design stage and what pitfalls to avoid

You may also be interested in...



Bucking the Regulatory Affairs and Quality Outsourcing Trends

John Avellanet reports on a survey that highlights the problems relating to the oversight of suppliers and outsourced contractors and explains how they can be avoided.

Bucking the Regulatory Affairs and Quality Outsourcing Trends

John Avellanet reports on a survey that highlights the problems relating to the oversight of suppliers and outsourced contractors and explains how they can be avoided.

How to Meet Compliance and Records Requirements of the US Food and Drug Administration

Records prove compliance. So why did 271 pharmaceutical and medical technology companies in the past 14 months receive regulatory enforcement notices from the US Food and Drug Administration citing records-related failures such as “failure to maintain accurate, complete, and current records”1 or “failure to retain all required records”2? Did the executives in these companies confuse standard operating procedures with FDA compliance?

Topics

UsernamePublicRestriction

Register

MT045332

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel